Stock Screener App

무료 -

2.574

2.70% +0.0677

시장 영업 전: 2.57 -0.004 -0.16%

Innate Pharma ADR (IPHA)

개요 뉴스 가격 이력 토론 예측

Innate Pharma ADR 주식(IPHA)의 최신 뉴스

Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress - Investing.com

All You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy

Zacks Investment Research

IPHA Stock Quote Price and Forecast - CNN

Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study

Zacks Investment Research

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities News

$76.97

4.27%

$151.22

2.59%

$29.65

1.89%

$171.03

3.73%

$376.60

0.10%

$92.98

0.85%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기